Lady Shadow will not be able to race at Meadowlands

from the Meadowlands Media Relations Department

East Rutherford, NJ — The Meadowlands Racetrack is announcing that Lady Shadow, an earner of $1,915,777 and the 2016 Dan Patch Award winner as champion pacing mare, will be unable to race at the Meadowlands after a post-race test at Harrah’s Philadelphia on May 28 came back positive for Clenbuterol.

According to the ruling issued by the Pennsylvania Horse Racing Commission, “Ronald Adams as trainer is in violation of PHRC medication rules and the trainer responsibility rule. Mr. Adams has waived his hearing before the Judges and will appeal the ruling to the Racing Commission. All purse money earned on 5/28/2017 must be returned and redistributed. Transfers of horses must be approved by the Judges at Harrah’s Chester or by the PHRC.”

“As a result of the finding that Lady Shadow was found to have unacceptable levels of Clenbuterol when she raced at Harrah’s Philadelphia and the split sample came back positive, the owners have been advised that the horse will not be allowed to race in the upcoming stake at the Meadowlands,” said Meadowlands chairman Jeffrey Gural.

For more information, visit www.playmeadowlands.com.

Related Articles:

  • The SBOANJ responds to the Lady Shadow matter (Tuesday, August 01, 2017)
    The SBOANJ, on behalf of the horsemen of New Jersey, believes it must address the Meadowlands Racetrack’s decision to ban Lady Shadow from the Lady Liberty Stakes this Saturday (Aug. 5).

Back to Top

Share via